Annual report disclosure progress! QFII's latest holdings are clarified, with a focus on pharmaceuticals, biotechnology, and manufacturing industries.

Source: Global Times

【Global Times Financial Report】As the disclosure process for listed companies’ 2025 annual reports progresses, the latest holdings of foreign institutions such as QFII in the A-share market are becoming clearer. As of March 22, a total of 41 listed companies appear in the QFII heavy holdings list, with 77 positions involving 16 foreign institutions.

Oriental IC

In terms of institutional distribution, Swiss United Bank Group, Barclays, Morgan Stanley, Goldman Sachs, JPMorgan Chase, and others remain highly active. Sovereign funds such as Abu Dhabi Investment Authority, Kuwait Investment Authority, and Macau Monetary Authority continue to appear as shareholders in pharmaceutical, energy, and equipment manufacturing companies. Goldman Sachs, Morgan Stanley, JPMorgan Chase, BNP Paribas, and Merrill Lynch International frequently invest in semiconductors, hardware equipment, electrical equipment, and auto parts.

Specifically, Abu Dhabi Investment Authority continues to increase its holdings in Baofeng Energy, holding 44.81 million shares at the end of last year, an increase of 400,000 shares from the previous period, with a market value of 880 million yuan. Goldman Sachs International increased its holdings of Shahe Shares by 1.137 million shares, and added 459,000 shares of *ST Songfa. The Goldman Sachs Group increased its stake in Shengtun Mining by 1.326 million shares. JPMorgan Chase increased its holdings of Zhejiang Liming by 1.191 million shares. Kunming Pharmaceutical Group also saw increased holdings, with Kuwait Investment Authority holding 5.9068 million shares, an increase of 857,800 shares from the previous period.

There are also reductions. Abu Dhabi Investment Authority slightly reduced its holdings in China Railway Construction Heavy Industry; Goldman Sachs International reduced its holdings of Xiechuang Data by 1.6275 million shares; Macau Monetary Authority reduced its holdings of Kunming Pharmaceutical by 3.268 million shares. In stocks like Hengdian Film & TV, Xidaomen, *ST Songfa, and Sanchao New Materials, Swiss United Bank Group and Morgan Stanley also showed varying degrees of reduction.

Additionally, Swiss United Bank Group newly invested in 12 companies including Demingli, Xin Nuo Wei, Ultrasonic Electronics, and Baosheng Shares; Morgan Stanley entered new positions in Jinhaitong, Baosheng Shares, Yanjiang Shares, Stitek, and Zhejiang Liming; JPMorgan Chase also newly invested in Zhongxing Junye, Dawei Shares, Stitek, Quoxin Shares, Shahe Shares, and Chaoyang Technology. The Goldman Sachs Group also entered the top ten circulating shareholders of companies like Feilong Shares, Bomaike, and Tianhong Shares.

In terms of industry distribution, the focus of QFII’s current disclosed holdings is relatively concentrated. Manufacturing remains the primary allocation sector. Among the 41 listed companies, most are manufacturing firms involved in semiconductors, hardware equipment, electrical equipment, machinery, auto parts, and chemicals. Pharmaceuticals and biotech form another clear main line. The pharmaceutical companies on the list include Xin Nuo Wei, China Resources Sanjiu, Kunming Pharmaceutical Group, Dong’e E Jiao, Huangshan Capsules, and New World. (Nanmu)